David Reddy
David Reddy is the director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), where he plays a critical role in shaping policies related to the pharmaceutical industry and public health. He has been an advocate for collaboration between governments and the pharmaceutical sector to enhance global health preparedness and response, particularly in the face of pandemics. Reddy's insights are influential in discussions about vaccine equity and the distribution of medical technologies, especially for developing countries.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| France | 1 | 6.00 | 0.05% | +0% | 65,273,511 | 32,637 | $2,700,000 | 1,350$ |
| Brazil | 1 | 5.00 | 0.04% | +0% | 211,049,527 | 89,163 | $1,500,000 | 634$ |
| New Zealand | 1 | 6.00 | 0.04% | +0% | 4,822,233 | 2,111 | $210,000 | 92$ |
| Totals | 3 | 281,145,271 | 123,911 | $4,410,000 | 2,076$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Brazil:
David Reddy emphasized the importance of intellectual property and legal security for ensuring investments in the pharmaceutical sector.
5
New Zealand:
David Reddy, director-general of the International Federation of Pharmaceutical Manufacturers and Associations, said the pandemic agreement is a starting point.
6
France:
David Reddy is the Director General of the International Federation of Pharmaceutical Manufacturers and Associations.
6